Hutchens & Kramer Investment Management Group LLC Reduces Position in The Cooper Companies, Inc. (NASDAQ:COO)

Hutchens & Kramer Investment Management Group LLC lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,178 shares of the medical device company’s stock after selling 884 shares during the period. Hutchens & Kramer Investment Management Group LLC’s holdings in Cooper Companies were worth $844,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of COO. Public Sector Pension Investment Board boosted its holdings in shares of Cooper Companies by 71.7% in the 2nd quarter. Public Sector Pension Investment Board now owns 7,590 shares of the medical device company’s stock valued at $663,000 after acquiring an additional 3,170 shares during the last quarter. MBB Public Markets I LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at $1,261,000. Magnolia Capital Advisors LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at $211,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Cooper Companies by 23.4% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,868 shares of the medical device company’s stock valued at $163,000 after acquiring an additional 354 shares during the last quarter. Finally, Wallace Advisory Group LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at $290,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $99.35 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a fifty day moving average of $95.95 and a two-hundred day moving average of $99.50. The stock has a market capitalization of $19.83 billion, a PE ratio of 50.95, a P/E/G ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.87 earnings per share. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Citigroup lowered their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.